This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
G-Tech Medical
Visit WebsitePortfolio company
United States
Sector: Medical Devices & Diagnostics
The company is developing disruptive technology to help diagnose the root causes of Functional Gastrointestinal Disorders (‘FGIDs’) that afflict more than 60 million people annually in the US alone.
Its technology is designed to address clinical and market needs to dramatically improve care for patients, providers and institutions; and to reduce costs associated with this disease.
Subsidiaries
Portfolio
- ProAxsis
- Glycotest
- Cetromed
- PDS Biotechnology
- Vortex Biosciences
- Wanda Health
- Q-Bot
- Sofant Technologies
- PointGrab
- SageTech Medical
- Dname-iT
- Oncocidia
- Ventive
- DeepTech Recycling
- G-Tech Medical
- FOx Biosystems
- EpiBone
- Cytovale
- Longevity Biotech
- QuantalX Neuroscience
- Insight Photonics
- Nanotech Industrial Solutions
- Martlet Capital